Insulin-like growth factors and subsequent risk of mortality in the United States

American Journal of Epidemiology

Volumn 166, Issue 5, 2007, Pages 518-526

  Saydah, Sharon ^a   Graubard, Barry ^b   Ballard Barbash, Rachel ^b   Berrigan, David ^b  

^a NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Heart diseases; Insulin like growth factor binding protein 3; Insulin like growth factor I; Mortality; Neoplasms; Nutrition surveys

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

CANCER; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; HEALTH SURVEY; HORMONE; MORTALITY RISK; PROTEIN;

ADULT; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEART DISEASE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; NUTRITION SURVEYS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SOMATOMEDINS; UNITED STATES;

NORTH AMERICA; UNITED STATES;

EID: 34548015443     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm124     Document Type: Article

References (39)

1. LeRoith D, Clemmons D, Nissley P, et al. NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med 1992;116:854-62.
2. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003;13:113-70.
3. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004;4:505-18.
4. Beers MH, Berkow R, eds. The Merck manual of diagnosis and therapy. 17th ed. Whitehouse Station, NJ: Merck Research Laboratories, 1999.
5. Rosen CJ. Serum insulin-like growth factors and insulin-like growth factor-binding proteins: clinical implications. Clin Chem 1999;45(8 pt 2):1384-90.
6. Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
7. Goodman-Gruen D, Barrett-Connor E, Rosen C. IGF-1 and ischemic heart disease in older people. J Am Geriatr Soc 2000;48:860-1.
8. Janssen JA, Stolk RP, Pols HA, et al. Serum free IGF-I, total IGF-I, IGF-BP1 and IGF-BP3 levels in an elderly population: relation to age and sex steroid levels. Clin Endocrinol (Oxf) 1998;48:471-8.
9. Janssen JA, Stolk RP, Pols HA, et al. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 1998;18:277-82.
10. Juul A, Scheike T, Davidsen M, et al. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002;106:939-44.
11. Conti E, Andreotti F, Sciahbasi A, et al. Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol 2001;38:26-32.
12. Reeves I, Abribat T, Laramee P, et al. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction. Growth Horm IGF Res 2000;10:78-84.
13. Vasan RS, Sullivan LM, D'Agostino RB, et al. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 2003;139:642-8.
14. Denti L, Annoni V, Cattadori E, et al. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 2004;117:312-17.
15. Chan JM, Stampfer MJ, Ma J, et al. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002;94:1099-106.
16. Lin Y, Tamakoshi A, Kikuchi S, et al. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer 2004;110:584-8.
17. Parker AS, Cheville JC, Janney CA, et al. High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas. Hum Pathol 2002;33:801-5.
18. Petridou E, Skalkidou A, Dessypris N, et al. Insulin-like growth factor binding protein-3 predicts survival from acute childhood leukemia. Oncology 2001;60:252-7.
19. Rocha RL, Hilsenbeck SG, Jackson JG, et al. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res 1997;3:103-9.
20. Wakai K, Ito Y, Suzuki K, et al. Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study. Jpn J Cancer Res 2002;93:1279-86.
21. Yu H, Levesque MA, Khosravi MJ, et al. Insulin-like growth factor-binding protein-3 and breast cancer survival. Int J Cancer 1998;79:624-8.
22. Laughlin GA, Barrett-Connor E, Criqui MH, et al. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab 2004;89:114-20.
23. Harrela M, Qiao Q, Koistinen R, et al. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Horm Metab Res 2002;34:144-9.
24. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Series 1: programs and collection procedures. Vital Health Stat 1 1994;Jul:1-407.
25. National Center for Health Statistics. Analytic and reporting guidelines: The Third National Health and Nutrition Examination Survey, NHANES III, 1988-94. Vol 32. Hyattsville, MD: National Center for Health Statistics, Centers for Disease Control and Prevention, 1996.
26. Berrigan D, Potischman N, Dodd K, et al. Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding protein-3: quality control for studies of stored serum. Cancer Epidemiol Biomarkers Prev 2007;16:1017-22.
27. Anderson RN, Minino AM, Hoyert DL, et al. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 2001;49:1-32.
28. Research Triangle Institute. SUDAAN, release 9.1. Research Triangle Park, NC: Research Triangle Institute, 2004.
29. Korn EL, Graubard BI. Analysis of health surveys. Wiley series in probability and statistics. New York, NY: John Wiley & Sons, 1999.
30. Mohamed-Ali V, Pinkney JH, Panahloo A, et al. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome. Clin Endocrinol (Oxf) 1999;50:221-8.
31. Suikkari AM, Koivisto VA, Rutanen EM, et al. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 1988;66:266-72.
32. Gibson JM, Westwood M, Young RJ, et al. Reduced insulin-like growth factor binding protein-1 (IGF-BP1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). J Clin Endocrinol Metab 1996;81:860-3.
33. Ferry RJ Jr, Cerri RW, Cohen P. Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res 1999;51:53-67.
34. Goldspink G. Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting. Int J Biochem Cell Biol 2006;38:481-9.
35. Newman AB, Kupelian V, Visser M, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci 2006;61:72-7.
36. Yang J, Anzo M, Cohen P. Control of aging and longevity by IGF-I signaling. Exp Gerontol 2005;40:867-72.
37. Berrigan D, Perkins SN, Haines DC, et al. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 2002;23:817-22.
38. Hursting SD, Lavigne JA, Berrigan D, et al. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003;54:131-52.
39. Goodman-Gruen D, Barrett-Connor E. Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-6.